Alys Pharmaceuticals

About:

Alys Pharmaceuticals is a biopharmaceutical company focused on developing immuno-dermatology treatments.

Top Investors: Medicxi

Description:

Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.

Total Funding Amount:

$100M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2024-01-01

Contact Email:

info(AT)alyspharma.com

Founders:

Brian Kim, Craig Mello, Eric Deutsch, John Harris, Lars French, Mark Prausnitz, Thibaud Portal

Number of Employees:

11-50

Last Funding Date:

2024-02-12

IPO Status:

Private

Industries: